MYMD1

MYMD1 · TNF Pharmaceuticals, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MYMD1, covering 2023-10-30 to 2023-10-30. Get the full timeline:

Most recent: Clinical Trial Update: Evaluation of Efficacy, Tolerability, and Pharmacokinetics of MYMD1 for Chronic Inflammation and Sarcopenia/Frailty [Phase 2]

See pricing